Cardiovascular complications of chronic rheumatic diseases, An Issue of Rheumatic Disease Clinics of North America. The Clinics: Internal Medicine Volume 49-1

Table of Contents

Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases: An Integrative, Multiparametric Approach
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights
Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies
Venous Thromboembolism in the Inflammatory Rheumatic Diseases
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?

Authors

M. Elaine Husni? Vice Chair, Dept of Rheumatic and immunologic diseases, Staff Physician, Orthopedic and Rheumatologic Institute, Cleveland Clinic. George A. Karpouzas Professor of Medicine, David Geffen School of Medicine at UCLA, Chief, Division of Rheumatology, Harbor-UCLA Medical Center, The Lundquist Institute of Biomedical Innovation.